Here are four highlights:
1. As predicted, Stryker acquired the ENT company for $662 million.
2. Entellus Medical focuses on providing minimally invasive solutions for various ear, nose and throat conditions.
3. Entellus Medical has a range of products, including the XprESS multi-sinus dilation system and Latera absorbable nasal implant.
4. The acquisition is anticipated to dilute Stryker’s 2018 adjusted net earnings by $0.04 per share.
More articles on devices and implants:
Medtronic, Stryker, Smith & Nephew and DePuy Synthes lead global orthopedics market — 5 observations
Leader Biomedical to acquire International Orthopaedics, expand global operations: 3 insights
ConforMIS iTotal CR knee replacement system awarded 3A rating: 4 insights
